XMD17-109,
1435488-37-1,
CHEMBL2381340,
11-cyclopentyl-2-[2-ethoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]anilino]-5-methylpyrimido[4,5-b][1,4]benzodiazepin-6-one,
GTPL9406,
SCHEMBL16065687,
AOB87761,
BCP09844,
EX-A2184,
XMD17109,
BDBM50434070,
s7334,
ZINC96270216,
AKOS025147359,
ACN-043338,
CS-1436,
SB19431,
KS-000006B1,
compound 26 [PMID: 24239623],
NCGC00378965-03,
11-Cyclopentyl-2-[[2-ethoxy-4-[[4-(4-methyl-1-piperazinyl)-1-piperidinyl]carbonyl]phenyl]amino]-5,11-dihydro-5-methyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one,
BC600637,
HY-15665,
QC-11620,
SC-95573,
A14090,
W-6135,
J-504144,
11-cyclopentyl-2-((2-ethoxy-4-(4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl)phenyl)amino)-5-methyl-5,11-dihydro-6H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6-one,
11-Cyclopentyl-2-[[2-ethoxy-4-[[4-(4-methyl-1-piperazinyl)-1-piperidinyl]carbonyl]phenyl]amino]-5,11-dihydro-5-methyl-6H-Pyrimido[4, 5-b][1,4]benzodiazepin-6-one,
6H-Pyrimido[4,5-b][1,4]benzodiazepin-6-one, 11-cyclopentyl-2-[[2-ethoxy-4-[[4-(4-methyl-1-piperazinyl)-1-piperidinyl]carbonyl]phenyl]amino]-5,11-dihydro-5-methyl-,
ERK5-IN-1,
IWP L6,
XMD17 109,
,XMD17-109,
A3942,
1427782-89-5,